Cargando…
An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication
A class of dihydropyranobenzimidazole inhibitors was recently discovered that acts against the hepatitis C virus (HCV) in a new way, binding to the IRES-IIa subdomain of the highly conserved 5' untranslated region of the viral RNA and thus preventing the ribosome from initiating translation. Ho...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259416/ https://www.ncbi.nlm.nih.gov/pubmed/21193848 http://dx.doi.org/10.3390/molecules16010281 |
_version_ | 1783374673923276800 |
---|---|
author | Parker, Matthew A. Satkiewicz, Emily Hermann, Thomas Bergdahl, B. Mikael |
author_facet | Parker, Matthew A. Satkiewicz, Emily Hermann, Thomas Bergdahl, B. Mikael |
author_sort | Parker, Matthew A. |
collection | PubMed |
description | A class of dihydropyranobenzimidazole inhibitors was recently discovered that acts against the hepatitis C virus (HCV) in a new way, binding to the IRES-IIa subdomain of the highly conserved 5' untranslated region of the viral RNA and thus preventing the ribosome from initiating translation. However, the reported synthesis of these compounds is lengthy and low-yielding, the intermediates are troublesome to purify, and the route is poorly structured for the creation of libraries. We report a streamlined route to this class of inhibitors in which yields are far higher and most intermediates are crystalline. In addition, a key variable side chain is introduced late in the synthesis, allowing analogs to be easily synthesized for optimization of antiviral activity. |
format | Online Article Text |
id | pubmed-6259416 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62594162018-12-07 An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication Parker, Matthew A. Satkiewicz, Emily Hermann, Thomas Bergdahl, B. Mikael Molecules Article A class of dihydropyranobenzimidazole inhibitors was recently discovered that acts against the hepatitis C virus (HCV) in a new way, binding to the IRES-IIa subdomain of the highly conserved 5' untranslated region of the viral RNA and thus preventing the ribosome from initiating translation. However, the reported synthesis of these compounds is lengthy and low-yielding, the intermediates are troublesome to purify, and the route is poorly structured for the creation of libraries. We report a streamlined route to this class of inhibitors in which yields are far higher and most intermediates are crystalline. In addition, a key variable side chain is introduced late in the synthesis, allowing analogs to be easily synthesized for optimization of antiviral activity. MDPI 2010-12-30 /pmc/articles/PMC6259416/ /pubmed/21193848 http://dx.doi.org/10.3390/molecules16010281 Text en © 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Parker, Matthew A. Satkiewicz, Emily Hermann, Thomas Bergdahl, B. Mikael An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title | An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title_full | An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title_fullStr | An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title_full_unstemmed | An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title_short | An Efficient New Route to Dihydropyranobenzimidazole Inhibitors of HCV Replication |
title_sort | efficient new route to dihydropyranobenzimidazole inhibitors of hcv replication |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259416/ https://www.ncbi.nlm.nih.gov/pubmed/21193848 http://dx.doi.org/10.3390/molecules16010281 |
work_keys_str_mv | AT parkermatthewa anefficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT satkiewiczemily anefficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT hermannthomas anefficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT bergdahlbmikael anefficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT parkermatthewa efficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT satkiewiczemily efficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT hermannthomas efficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication AT bergdahlbmikael efficientnewroutetodihydropyranobenzimidazoleinhibitorsofhcvreplication |